Top

Published in:

01-06-2008 | Case Report

1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence

Authors: L. K. Carr, D. Steele, S. Steele, D. Wagner, R. Pruchnic, R. Jankowski, J. Erickson, J. Huard, M. B. Chancellor

Published in: International Urogynecology Journal | Issue 6/2008

Abstract

We hereby report a 1-year follow-up on eight women in the first North America trial in which stress urinary incontinence (SUI) was treated with muscle-derived stem cell injections. Mean and median follow-up in this group was 16.5 and 17 months (range 3–24 months). Improvement in SUI was seen in five of eight women, with one achieving total continence. Onset of improvement was between 3 and 8 months after injection. Cure or improvement continued at a median of 10 months. No serious adverse events were reported.

Norton P, Brubaker L (2006) Urinary incontinence in women. Lancet 367:57–67PubMedCrossRef

Kiilholma P, Chancellor MB, Makinen J, Hirsch IH, Klemi PJ (1993) Complications of Teflon injections for stress urinary incontinence. Neurourol Urodyn 12:131–137PubMedCrossRef

Huard J, Yokoyama T, Pruchnic R, Qu Z, Li Y, Lee JY, Somogyi GT, de Groat WT, Chancellor MB (2002) Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction. Gene Ther 9:1617–1626PubMedCrossRef

Rodriguez LV, Alfonso Z, Zhang R, Leung J, Wu B, Ignarro LJ (2006) Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. PNAS 103:12167–12172PubMedCrossRef

Strasser H, Marksteiner R, Margreiter E (2006) Transurethral ultrasound guided stem cell therapy of urinary incontinence. J Urol 175:291–292CrossRef

Oshima H, Payne TR, Urish KL, Sakai T, Ling Y, Gharaibeh B, Tubita K, Keller BB, Cummins JH, Huard J (2005) Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12:1130–1141PubMedCrossRef

Lee JY, Qu-Petersen Z, Cao B, Kimura S, Jankowski R, Cummins J, Usas A, Gates G, Robbins P, Wernig A, Huard J (2000) Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150:1085–1100PubMedCrossRef

Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R, Mytinger J, Cao B, Gates C, Wernig A, Huard J (2002) Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157:851–864PubMedCrossRef

Kwon D, Kim Y, Pruchnic R, Jankowski R, Isiene I, de Miguel F, Huard J, Chancellor MB (2006) Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence. Urology 68:449–454PubMedCrossRef

Title: 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence
Authors: L. K. Carr
D. Steele
S. Steele
D. Wagner
R. Pruchnic
R. Jankowski
J. Erickson
J. Huard
M. B. Chancellor
Publication date: 01-06-2008
Publisher: Springer-Verlag
Published in: International Urogynecology Journal / Issue 6/2008
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-007-0553-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2008

The use of polypropylene mesh as a transobturator sling for the treatment of female stress urinary incontinence (early experience with 40 cases)

Update: the “Contiform” intravaginal device in four sizes for the treatment of stress incontinence

Nip, tuck, and rejuvenate: the latest frontier for the gynecologic surgeon—reply to comment by Pardo et al.

Predictors of successful voiding before hospital discharge after urinary stress incontinence surgery

Nip, tuck and rejuvenate: the latest frontier for the gynecologic surgeon: reply to Miklos and Moore

Where should bulking agents for female urodynamic stress incontinence be injected?